Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
7 Veni-beurzen voor MDL-onderzoek
aug 2024 | Hepatologie, IBD, Immuuntherapie, Maag-darm-leveroncologie, Pancreatitis, Parasitaire infecties